Cargando…

Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies

BACKGROUND: There have been contradictory findings regarding the relationship between serum uric acid levels and prognosis in acute ischemic stroke. Whether this association is nonlinear due to uric acid’s paradoxical properties (antioxidant and prooxidant) is unclear. METHODS: We searched PubMed, W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenyuan, Cheng, Zicheng, Fu, Fangwang, Zhan, Zhenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505709/
https://www.ncbi.nlm.nih.gov/pubmed/37727320
http://dx.doi.org/10.3389/fnagi.2023.1223015
_version_ 1785106960400515072
author Zhang, Wenyuan
Cheng, Zicheng
Fu, Fangwang
Zhan, Zhenxiang
author_facet Zhang, Wenyuan
Cheng, Zicheng
Fu, Fangwang
Zhan, Zhenxiang
author_sort Zhang, Wenyuan
collection PubMed
description BACKGROUND: There have been contradictory findings regarding the relationship between serum uric acid levels and prognosis in acute ischemic stroke. Whether this association is nonlinear due to uric acid’s paradoxical properties (antioxidant and prooxidant) is unclear. METHODS: We searched PubMed, Web of Science, and Embase databases until December 2022. Cohort studies reporting serum uric acid levels and functional outcome, mortality, or neurological complications in patients with acute ischemic stroke were included. Summary effect estimates were calculated using a random-effect model. Moreover, dose–response relationships were assessed by the generalized least squares trend estimation. RESULTS: Altogether, 13 cohort studies were identified in this study. Compared to the lowest baseline serum uric acid levels, the highest levels were associated with decreased risk of poor functional outcome (OR = 0.70, 95% CI 0.54–0.91, I(2) = 29%), hemorrhagic transformation (OR = 0.15, 95% CI 0.05–0.42, I(2) = 79%), and post-stroke depression (OR = 0.04, 95% CI 0.00–0.95, I(2) = 89%), but not associated with mortality and symptomatic intracerebral hemorrhage. A nonlinear relationship was observed in poor functional outcome (U-shaped, P for nonlinearity = 0.042), hemorrhagic transformation (inverse, P for nonlinearity = 0.001), and post-stroke depression (inverse, P for nonlinearity = 0.002). In addition, there was a single study reporting a U-shaped association in post-stroke epilepsy (P for nonlinearity <0.001). Furthermore, another study reported a positive curvilinear association in stroke recurrence (P for nonlinearity <0.05). The insufficient number of original articles for some prognostic indicators should be considered when interpreting the results of this meta-analysis. CONCLUSION: In patients with acute ischemic stroke, serum uric acid levels are nonlinearly associated with the risk of poor functional outcome (U-shaped). More evidence is needed to confirm the association between serum uric acid levels and neurological complications following acute ischemic stroke.
format Online
Article
Text
id pubmed-10505709
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105057092023-09-19 Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies Zhang, Wenyuan Cheng, Zicheng Fu, Fangwang Zhan, Zhenxiang Front Aging Neurosci Aging Neuroscience BACKGROUND: There have been contradictory findings regarding the relationship between serum uric acid levels and prognosis in acute ischemic stroke. Whether this association is nonlinear due to uric acid’s paradoxical properties (antioxidant and prooxidant) is unclear. METHODS: We searched PubMed, Web of Science, and Embase databases until December 2022. Cohort studies reporting serum uric acid levels and functional outcome, mortality, or neurological complications in patients with acute ischemic stroke were included. Summary effect estimates were calculated using a random-effect model. Moreover, dose–response relationships were assessed by the generalized least squares trend estimation. RESULTS: Altogether, 13 cohort studies were identified in this study. Compared to the lowest baseline serum uric acid levels, the highest levels were associated with decreased risk of poor functional outcome (OR = 0.70, 95% CI 0.54–0.91, I(2) = 29%), hemorrhagic transformation (OR = 0.15, 95% CI 0.05–0.42, I(2) = 79%), and post-stroke depression (OR = 0.04, 95% CI 0.00–0.95, I(2) = 89%), but not associated with mortality and symptomatic intracerebral hemorrhage. A nonlinear relationship was observed in poor functional outcome (U-shaped, P for nonlinearity = 0.042), hemorrhagic transformation (inverse, P for nonlinearity = 0.001), and post-stroke depression (inverse, P for nonlinearity = 0.002). In addition, there was a single study reporting a U-shaped association in post-stroke epilepsy (P for nonlinearity <0.001). Furthermore, another study reported a positive curvilinear association in stroke recurrence (P for nonlinearity <0.05). The insufficient number of original articles for some prognostic indicators should be considered when interpreting the results of this meta-analysis. CONCLUSION: In patients with acute ischemic stroke, serum uric acid levels are nonlinearly associated with the risk of poor functional outcome (U-shaped). More evidence is needed to confirm the association between serum uric acid levels and neurological complications following acute ischemic stroke. Frontiers Media S.A. 2023-09-01 /pmc/articles/PMC10505709/ /pubmed/37727320 http://dx.doi.org/10.3389/fnagi.2023.1223015 Text en Copyright © 2023 Zhang, Cheng, Fu and Zhan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Zhang, Wenyuan
Cheng, Zicheng
Fu, Fangwang
Zhan, Zhenxiang
Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title_full Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title_fullStr Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title_full_unstemmed Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title_short Serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
title_sort serum uric acid and prognosis in acute ischemic stroke: a dose–response meta-analysis of cohort studies
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505709/
https://www.ncbi.nlm.nih.gov/pubmed/37727320
http://dx.doi.org/10.3389/fnagi.2023.1223015
work_keys_str_mv AT zhangwenyuan serumuricacidandprognosisinacuteischemicstrokeadoseresponsemetaanalysisofcohortstudies
AT chengzicheng serumuricacidandprognosisinacuteischemicstrokeadoseresponsemetaanalysisofcohortstudies
AT fufangwang serumuricacidandprognosisinacuteischemicstrokeadoseresponsemetaanalysisofcohortstudies
AT zhanzhenxiang serumuricacidandprognosisinacuteischemicstrokeadoseresponsemetaanalysisofcohortstudies